Evolent program achieves 20% reduction in use of low-value oncology regimens

Go back to Evolent program achieves 20% reduction in use of low-value oncology regimens
(NYSE: EVH) Delayed: 3.96 --0 (-0%)
Previous Close $3.96    52 Week High $26.84 
Open $3.96    52 Week Low $8.14 
Day High $3.96    P/E N/A 
Day Low $3.96    EPS $0.00 
Volume 93